What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer?

Current Oncology

Volumn 17, Issue 6, 2010, Pages 46-51

  Yu, E ^a   Tai, P ^b   Malthaner, R ^a   Stitt, L ^a   Rodrigues, G ^a   Dar, R ^a   Yaremko, B ^a   Younus, J ^a   Sanatani, M ^a   Vincent, M ^a   Dingle, B ^a   Fortin, D ^a   Inculet, R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Allan Blair Cancer Centre   (Canada)

Author keywords

Cancer; Esophagus; Interval; Relapse; Resection margin

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; DISEASE FREE INTERVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEGAVOLTAGE RADIOTHERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; SURVIVAL RATE;

EID: 78650157738     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i6.561     Document Type: Article

References (17)

1. Saga PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Signifcance of circumferential resection margin involvement after oesphagectomy for cancer. Br J Surg 1993;80:1386-1388.
2. Dexter SPL, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001;48:667-670.
3. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy J P. Prognostic signifcance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 2003; 88:1549-1552.
4. Alexiou C, Khan O, Black E, et al. Survival after esophageal resection for carcinoma: the importance of the histologic cell type. Ann Thorac Surg 2006;82:1037-1037.
5. Shimada H, Kitabayasshi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133: 24-31.
6. Bedard E, Inculet R I, Malthaner R, Brecevic E, Vincent M, Dar R. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001;91:2423-2430.
7. Rice TW, Adelstein DJ, Chidel MA, et al. Beneft of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003:126;1590-1596.
8. Yu E, Dar R, Rodrigues G, et al. Is extended volume external beam radiation therapy covering the anastomotic site benefcial in post-esophagectomy high risk patients? Radiother Oncol 2004; 73: 141-14 8.
9. Nakamura T, Ota M, Narumiya K, et al. Multimodal treatment for lymph node recu r rence of esophageal carcinoma af ter curative resection. Annu Surg Oncol 2008; 15: 2451-2457.
10. Javle M, Ailawadhi S, Yang GY, Nwogu CE, Schiff MD, Nava HR. Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol 2006;4:365-373,379.
11. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
12. Herskovic A, Montz LK, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of esophagus. N Engl J Med 1992;326:1593-1598.
13. Kaplan EL, Meier P. Nonpa ra metric est imat ion from i ncomplete observation. J Am Stat Assoc 1958;53:457-481.
14. Hosmer DW Jr, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: Wiley; 1999.
15. Roch MS, Lee JI, Choi PJ. Signifcance of circumferential resection margin involvement following esophagectomy for esophageal cancer. Korean J Pathol 2004;38:23-28.
16. Harpole DH, Moore MB, Herndon JE, et al. The prognostic valve of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res 2001;7: 562-569.
17. Wang CY, Hsieh MJ, Chiu YC, et al. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol 2009;92:270-275.